Erratum: PECAM-1 Ligation Negatively Regulates TLR4 Signaling in Macrophages (J. Immunol. (2007) 179 (7344-7351) DOI: 10.4049/jimmunol.179.11.7344);PECAM-1 ligation negatively regulates TLR4 signaling in macrophages

Journal of Immunology

Volumn 179, Issue 11, 2007, Pages 7344-7351

  Rui, Yuxiang ^a,b   Liu, Xingguang ^b   Li, Nan ^b   Jiang, Yingming ^b   Chen, Guoyou ^b   Cao, Xuetao ^a,b   Wang, Jianli ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CD31 ANTIGEN; CD38 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; HYBRID PROTEIN; I KAPPA B; INTERFERON REGULATORY FACTOR 3; MESSENGER RNA; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; PTPN11 PROTEIN, MOUSE; PTPN6 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME INHIBITION; INHIBITION KINETICS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL LINE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; HUMAN; IMMUNOLOGY; KINETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD31; ANTIGENS, CD38; CELL LINE; CYTOKINES; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; I-KAPPA B PROTEINS; INTERFERON REGULATORY FACTOR-3; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KINETICS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 11; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 38849124287     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.2300468     Document Type: Erratum

References (33)

1. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
2. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21: 335-376.
3. Medzhitov, R., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh, and C. A. Janeway. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell. 2: 253-258.
4. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, et al. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643.
5. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5: 987-995.
6. Ulevitch, R. J. 1999. Toll gates for pathogen selection. Nature 401: 755-756.
7. Liew, F. Y., D. Xu, E. K. Brint, and L. A. O'Neill. 2005. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5: 446-458.
8. Sweet, M. J., B. P. Leung, D. Kang, M. Sogaard, K. Schulz, V. Trajkovic, C. C. Campbell, D. Xu, and F. Y. Liew. 2001. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J. Immunol. 166: 6633-6639.
9. Nakagawa, R., T. Naka, H. Tsutsui, M. Fujimoto, A. Kimura, T. Abe, E. Seki, S. Sato, O. Takeuchi, K. Takeda, et al. 2002. SOCS-1 participates in negative regulation of LPS responses. Immunity 17: 677-687.
10. Newman, P. J. 1997. The biology of PECAM-1. J. Clin. Invest. 99: 3-8.
11. Newman, P. J. 1999. Switched at birth: a new family for PECAM-1. J. Clin. Invest. 103: 5-9.
12. Carrithers, M., S. Tandon, S. Canosa, M. Michaud, D. Graesser, and J. A. Madri. 2005. Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice. Am. J. Pathol. 166: 185-196.
13. Wang, T., D. J. Xia, N. Li, C. M. Wang, T. Y. Chen, T. Wan, G. Y. Chen, and X. T. Cao. 2005. Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis. J. Biol. Chem. 280: 4374-4382.
14. Han, Y. M., M. H. Zhang, N. Li, T. Y. Chen, Y. Zhang, T. Wan, and X. T. Cao. 2004. KLRL1, a novel killer cell lectinlike receptor, inhibits natural killer cell cytotoxicity. Blood 104: 2858-2866.
15. An, H. Z., H. M. Xu, M. H. Zhang, J. Zhou, T. Feng, C. Qian, R. Z. Qi, and X. T. Cao. 2005. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism. Blood 105: 4685-4692.
16. Gutierrez, M. G., S. S. Master, S. B. Singh, G. A. Taylor, M. I. Colombo, and V. Deretic. 2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119: 753-766.
17. Chan, J., P. J. Leenen, I. Bertoncello, S. I. Nishikawa, and J. A. Hamilton. 1998. Macrophage lineage cells in inflammation: characterization by colony-stimulating factor-1 (CSF-1) receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) expression. Blood 92: 1423-1431.
18. Shin, N. R., D. Y. Lee, S. J. Shin, K. S. Kim, and H. S. Yoo. 2004. Regulation of proinflammatory mediator production in Raw264.7 macrophage by Vibrio vulnificus luxS and smcR. FEMS Immunol. Med. Microbiol. 41: 169-176.
19. Horenstein, A. L., H. Stockinger, B. A. Imhof, and F. Malavasi. 1998. CD38 binding to human myeloid cells is mediated by mouse and human CD31. Biochem. J. 330: 1129-1135.
20. Maas, M., M. Stapleton, C. Bergom, D. L. Mattson, D. K. Newman, and P. J. Newman. 2005. Endothelial cell PECAM-1 confers protection against endotoxic shock. Am. J. Physiol. 288: H159-H164.
21. Khatri, S., J. H. Lass, F. P. Heinzel, W. M. Petroll, J. Gomez, E. Diaconu, C. M. Kalsow, and E. Pearlman. 2002. Regulation of endotoxin-induced keratitis by PECAM-1, MIP-2, and Toll-like receptor 4. Invest. Ophthalmol. Visual Sci. 43: 2278-2284.
22. Shen, Y., C. Sultana, M. Arditi, K. S. Kim, and V. K. Kalra. 1998. Endotoxin-induced migration of monocytes and PECAM-1 phosphorylation are abrogated by PAF receptor antagonists. Am. J. Physiol. 275: E479-E486.
23. Deaglio, S., M. Morra, R. Mallone, C. M. Ausiello, E. Prager, G. Garbarino, U. Dianzani, H. Stockinger, and F. Malavasi. 1998. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J. Immunol. 160: 395-402.
24. Mathur, R. K., A. Awasthi, P. Wadhone, B. Ramanamurthy, and B. Saha. 2004. Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat. Med. 10: 540-544.
25. Yi, A. K., J. G. Yoon, S. J. Yeo, S. C. Hong, B. K. English, and A. M. Krieg. 2002. Role of mitogen-activated protein kinases in CpG DNA-mediated IL-10 and IL-12 production: central role of extracellular signal-regulated kinase in the negative feedback loop of the CpG DNA-mediated Th1 response. J. Immunol. 168: 4711-4720.
26. Divanovic, S., A. Trompette, S. F. Atabani, R. Madan, D. T. Golenbock, A. Visintin, R. W. Finberg, A. Tarakhovsky, S. N. Vogel, Y. Belkaid, et al. 2005. Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105. Nat. Immunol. 6: 571-578.
27. Newton-Nash, D. K., and P. J. Newman. 1999. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J. Immunol. 163: 682-688.
28. Wilkinson, R., A. B. Lyons, D. Roberts, M. X. Wong, P. A. Bartley, and D. E. Jackson. 2002. Platelet endothelial cell adhesion molecule-1 (PECAM-1/ CD31) acts as a regulator of B-cell development: B-cell antigen receptor (BCR)-mediated activation, and autoimmune disease. Blood 100: 184-193.
29. Jones, K. L., S. C. Hughan, S. M. Dopheide, R. W. Farndale, S. P. Jackson, and D. E. Jackson. 2001. Platelet endothelial cell adhesion molecule-1 is a negative regulator of platelet-collagen interactions. Blood 98: 1456-1463.
30. Patil, S., D. K. Newman, and P. J. Newman. 2001. Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. Blood 97: 1727-1732.
31. Cicmil, M., J. M. Thomas, M. Leduc, C. Bon, and J. M. Gibbins. 2002. Platelet endothelial cell adhesion molecule-1 signaling inhibits the activation of human platelets. Blood 99: 137-144.
32. Henshall, T. L., K. L. Jones, R. Wilkinson, and D. E. Jackson. 2001. Src homology 2 domain-containing protein-tyrosine phosphatases: SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling. J. Immunol. 166: 3098-3106.
33. lck. Blood 97: 2351-2357.